APA (7th ed.) Citation

Citterio, C., Biasini, C., Nunzio, C. D., Cascio, G. L., & Cavanna, L. (2024). Humoral Response and Safety after a Fourth Dose of the SARS-CoV-2 BNT162b2 Vaccine in Cancer Patients Undergoing Active Treatment—Results of a Prospective Observational Study. MDPI AG.

Chicago Style (17th ed.) Citation

Citterio, Chiara, Claudia Biasini, Camilla Di Nunzio, Giuliana Lo Cascio, and Luigi Cavanna. Humoral Response and Safety After a Fourth Dose of the SARS-CoV-2 BNT162b2 Vaccine in Cancer Patients Undergoing Active Treatment—Results of a Prospective Observational Study. MDPI AG, 2024.

MLA (9th ed.) Citation

Citterio, Chiara, et al. Humoral Response and Safety After a Fourth Dose of the SARS-CoV-2 BNT162b2 Vaccine in Cancer Patients Undergoing Active Treatment—Results of a Prospective Observational Study. MDPI AG, 2024.